Furthermore, we have published data from a Phase II clinical trial demonstrating that EGCG, in the form of Polyphenon E, is able to decrease serum levels of prostate serum antigen (PSA), HGF and VEGF in men with prostate cancer [27]. Here, HGF is linked to prostate carcinoma.